Register
Login:
Share:
Email Facebook Twitter


EXCLUSIVE: David Lenigas answers investor questions in a detailed interview about UKOG, Doriemus, LGC Capital, AfriAg and Angus Energy.


Immupharma Share Chat (IMM)



Share Price: 98.50Bid: 97.00Ask: 98.50Change: 0.00 (0.00%)No Movement on Immupharma
Spread: 1.50Spread as %: 1.55%Open: 96.50High: 100.00Low: 96.50Yesterday’s Close: 98.50


Share Discussion for Immupharma


Thread View

Please login or register to post a message on Share Chat.

Posts per page:


PinWiz
Posts: 244
Off Topic
Opinion:No Opinion
Price:98.00
Strange
Fri 14:41
That's a lot of A trades;o
 
Lostinfrance
Posts: 113
Off Topic
Opinion:Strong Buy
Price:99.00
RE: 1 pound
Fri 11:56
Earthling i agree totally with you,
Ive been here over 4 years the highs and very lows, as someone once said easier to stay patient when your in profit.
Good times ahead for next year,
earthling
Posts: 7,037
Off Topic
Opinion:No Opinion
Price:99.00
1 pound
Fri 11:50
Barrier will be smashed soon enough IMO

With phase 3 results due in the New year I believe, we should see many multiples from here over coming months

I was in here many years ago but sold out

Managed to get back in recently and will be topping up before the year

Well done LTH s who have been in early door s

These pharmas with phase 3 results due are very rare indeed
IMO If this works out willnsee very good rewards from these
Holding longer term will see the biggest rewards

It's common also to be taken out by one of the larger pharmas once it's got approval
Lostinfrance
Posts: 113
Off Topic
Opinion:No Opinion
Price:99.00
Large spread
Fri 11:41
We have a large spread, 3 p, i wonder if its to take out any worried investors then hopefully next week another push up with buying,
Not too long to wait untill next year.
boomorbust
Posts: 9,209
Off Topic
Opinion:No Opinion
Price:100.00
RE: Proactive Forum
Wed 15:08
Thanks for taking the time and trouble to post Chelsea
CHELSEA7
Posts: 28,635
Premium Chat Member
Off Topic
Opinion:No Opinion
Price:99.00
Proactive Forum
Wed 13:38
Well done all here.................

Good morning,

You are warmly invited to attend Proactive Investors' One2One Healthcare Forum which is taking place on Thursday 2nd November at The Chesterfield Mayfair Hotel from 6pm. Presenting on the evening will be ImmuPharma (LON:IMM), Widecells (LON:WDC), Synairgen (LON:SDX) & Tissue Regenix (LON:TRX).

To register to attend please click on the panel to the right or reply to this email.

ImmuPharma (LON:IMM - Market Cap: £131 Million)

ImmuPharma is a pharmaceutical development company focussing on developing novel medicines with high sales potential in specialist markets with serious unmet need.

The company's lead product is Lupuzor which is a potential treatment for Lupus, a chronic and potentially life-threatening auto-immune disease.

Chairman Tim McCarthy will be in attendance to outline the investment proposition on offer at ImmuPharma.
L0ngterm
Posts: 85
Off Topic
Opinion:No Opinion
Price:102.00
RE: Interestingly
Tue 22:33
Would have said 1.10 previously but the rate this has jumped in short burst is impressive.
L0ngterm
Posts: 85
Off Topic
Opinion:No Opinion
Price:102.00
RE: Interestingly
Tue 22:28
1.50 for December, assuming rns released.
2.00 if rns and broker raises estimate
2.00 plus if rns, broker raises and further news on any other elements of the pipeline.
seagul
Posts: 196
Observation
Opinion:Strong Buy
Price:102.00
Share price
Tue 22:16
I think a deal before xmas otherwise they will take it forward on there own. Big risk but big rewards. Im thinking £2 before xmas
kash_
Posts: 153
Off Topic
Opinion:No Opinion
Price:102.00
RE: Interestingly
Tue 21:54
Good question there. If a deal is to be done it surely must be this quarter?? If no deal I don't have the balls to keep my entire holding. I've a 42p average and will sell most and wait for results. Anyone's guess but £1.30 plus I hope. ATB




Share Price, Share Chat, Stock Market news at lse.co.uk
FREE Member Services
- Setup a personalised Watchlist and Virtual Portfolio.
- Gain access to LIVE real-time Regulatory News (RNS).
- View more Trades, Directors' Deals, and Broker Ratings.
Share Price, Share Chat, Stock Market news at lse.co.uk






Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.